Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 373 entries
View as:

Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary Vaccine Regimens in Republic of South Africa

Phase: N/A Priority: Normal
NCT ID: NCT04300192 Org: User:
Start: 01/27/21 End: 01/11/23 Due: 01/11/24

Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01488890 Org: User:
Start: 12/06/11 End: 09/27/13 Due: 09/27/14

Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT01188343 Org: User:
Start: 08/31/10 End: 12/31/12 Due: 12/31/13

Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT02948933 Org: User:
Start: 12/14/16 End: 12/22/22 Due: 12/22/23

A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines

Phase: N/A Priority: Normal
NCT ID: NCT01949675 Org: User:
Start: 03/31/14 End: 08/31/15 Due: 08/31/16

Study on a MenACYW Conjugate Vaccine Administered as a Single Dose in Participants Aged 12 Months and Older in Vietnam

Phase: N/A Priority: Normal
NCT ID: NCT06228586 Org: User:
Start: 01/18/24 End: 03/31/24 Due: 03/31/25

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Japanese Adults 60 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT04498832 Org: User:
Start: 10/21/20 End: 01/14/21 Due: 01/14/22

Study of Purified Vero Rabies Vaccine and Rabies Human Diploid Cell Vaccine in a Simulated Rabies Post-exposure Regimen

Phase: N/A Priority: Normal
NCT ID: NCT01877395 Org: User:
Start: 06/30/13 End: 09/30/14 Due: 09/30/15

Safety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South Korea

Phase: N/A Priority: Normal
NCT ID: NCT01642589 Org: User:
Start: 07/31/12 End: 06/30/13 Due: 06/30/14

Dengvaxia US Pregnancy Registry

Phase: N/A Priority: Normal
NCT ID: NCT04486638 Org: User:
Start: 01/01/23 End: 06/30/29 Due: 06/30/30

Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy

Phase: N/A Priority: Normal
NCT ID: NCT05929651 Org: User:
Start: 09/07/23 End: 09/09/24 Due: 09/09/25

Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine Candidate in Healthy Adults (19-49 Years)

Phase: N/A Priority: Normal
NCT ID: NCT06698198 Org: User:
Start: 12/03/18 End: 09/30/19 Due: 09/30/20

Prospective Surveillance of Respiratory Syncytial Virus Disease in Infants and Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT05964582 Org: User:
Start: 07/11/23 End: 07/02/24 Due: 07/02/25

Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule

Phase: N/A Priority: Normal
NCT ID: NCT00315055 Org: User:
Start: 07/31/06 End: 02/29/08 Due: 02/28/09

Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine, in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4)

Phase: N/A Priority: Normal
NCT ID: NCT04084769 Org: User:
Start: 09/03/19 End: 09/14/20 Due: 09/14/21

Association of Host Genetics With Vaccine Efficacy and Study of Immune Correlates of Risk From a Tetravalent Dengue Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT02827162 Org: User:
Start: 03/29/16 End: 04/27/16 Due: 04/27/17

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

Phase: N/A Priority: Normal
NCT ID: NCT06316297 Org: User:
Start: 04/05/24 End: 08/31/28 Due: 08/31/29

Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine.

Phase: N/A Priority: Normal
NCT ID: NCT02697474 Org: User:
Start: 02/29/16 End: 01/31/17 Due: 01/31/18

A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years

Phase: N/A Priority: Normal
NCT ID: NCT00956202 Org: User:
Start: 08/31/09 End: 11/30/10 Due: 11/30/11

Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT01396512 Org: User:
Start: 07/31/11 End: 06/30/13 Due: 06/30/14

Immunogenicity and Safety of a Quadrivalent Influenza Vaccine Given by Intramuscular Route in Subjects Aged 18 to 60 Years

Phase: N/A Priority: Normal
NCT ID: NCT02550197 Org: User:
Start: 09/30/15 End: 07/31/16 Due: 07/31/17

Regulatory Post-Marketing Surveillance Study for Hepatitis A Vaccine (AVAXIM 160U)

Phase: N/A Priority: Normal
NCT ID: NCT01838070 Org: User:
Start: 04/30/13 End: 05/31/16 Due: 05/31/17

Study of a Single Dose or Two Doses of a Trivalent Inactivated Influenza Vaccine Produced at Shenzhen, China

Phase: N/A Priority: Normal
NCT ID: NCT02228980 Org: User:
Start: 09/30/14 End: 10/31/15 Due: 10/31/16

Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00746798 Org: User:
Start: 10/31/08 End: 12/31/09 Due: 12/31/10

Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT00524732 Org: User:
Start: 09/30/04 End: 09/30/05 Due: 09/30/06